Market News
Thursday, September 15, 2016
BRIEF-Teva launches authorized generic of Cubicin in the U.S.
* Teva strengthens injectables portfolio with the launch of
an authorized generic of Cubicin (Daptomycin for injection) in
the United States
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment